APA (7th ed.) Citation

Batool, R., Sadiq, M., Ghafoor, Q., Watkins, S., Karapanagiotou, E., Josephides, E., . . . Hafeez, T. (2024). 1387P Real-world data, tolerability and clinical outcomes in patients with advanced NSCLC treated with sotorasib in the UK. Annals of Oncology, 35, S869. https://doi.org/10.1016/j.annonc.2024.08.1442

Chicago Style (17th ed.) Citation

Batool, R., et al. "1387P Real-world Data, Tolerability and Clinical Outcomes in Patients with Advanced NSCLC Treated with Sotorasib in the UK." Annals of Oncology 35 (2024): S869. https://doi.org/10.1016/j.annonc.2024.08.1442.

MLA (9th ed.) Citation

Batool, R., et al. "1387P Real-world Data, Tolerability and Clinical Outcomes in Patients with Advanced NSCLC Treated with Sotorasib in the UK." Annals of Oncology, vol. 35, 2024, p. S869, https://doi.org/10.1016/j.annonc.2024.08.1442.